The Research Business Office provides services to investigators in various scopes, some of which are: grant application support, fiscal and administrative support, and clinical trial agreement development & execution.
Grant Application Support
- Prepares grant budget
- Develops consortium and subcontract agreements
- Collaborates with granting agencies
Fiscal and Administrative Support
- Reviews and accepts awards on behalf of The Queen's Medical Center (QMC)
- Establishes required financial accounts at QMC
- Manages revenues and expenses
- Ensures compliance with sponsors' fiscal terms and conditions
- Provides financial reports to investigators
Clinical Trial Agreement Development & Execution
- Reviews and finalizes agreement between sponsor and QMC
- Negotiates study budget with sponsor
- Collaborates with study sponsor and principal investigator
Schedule of Fees
The following are The Queen's Medical Center's start-up and ongoing fees for clinical trials. Inclusive of overhead, final fees are subject to contract negotiation. All start-up fees are assessed independent of IRB approval or subject enrollment and are non-refundable. All fees are subject to change. Please note that in addition to the business fees, your study will also occur IRB related fees.
- Start-up fees:
- Administrative Start-up - $3,000
- contract and budget negotiation
- document preparation for initial IRB review
- Coverage Analysis - $1,500
- Investigator Meetings - $3,000 (Principal investigator and study coordinator time spent traveling and attending meetings)
- Overhead - 35%
- Pharmacy Set-up - $3,500
- Lab Start-up Fees - $300
- Ongoing fees:
- Serious adverse events - $250 per occurence
- Investigational new drug - $150 per occurence
- Monitor site fee - $600 per visit
- Record Archiving - $500 per year
- Pharmacy dosing fee - to be determined per study
- Coverage Analysis per Protocol Amendment - $1,500
- Contract Amendment Admin Fee - $2,500
- IRB Submission Preparation Fee, per submission - $500
- Fee for the work performed for the preparation and submission of IRB submissions associated with initial, resubmissions or revisions of the Protocol, Informed Consent Documents, annual review, or reviews required for closure of the Study
- Close-out fees:
- Study closure fee - $1,500
- Pharmacy Close-Out Fee - to be determined per study
Contact Information
For any questions, contact:
Sheila Dela CruzManager, Research Business Office
Phone: 808.691.7409
Fax: 808.691.5079
E-mail: sdelacruz@queens.org